0001209191-15-040806.txt : 20150508
0001209191-15-040806.hdr.sgml : 20150508
20150508195258
ACCESSION NUMBER: 0001209191-15-040806
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150507
FILED AS OF DATE: 20150508
DATE AS OF CHANGE: 20150508
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HYPERION THERAPEUTICS INC
CENTRAL INDEX KEY: 0001386858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611512713
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-745-7802
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Santel Donald J
CENTRAL INDEX KEY: 0001293630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35614
FILM NUMBER: 15848544
MAIL ADDRESS:
STREET 1: 5000 SHORELINE COURT, SUITE 101
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-07
1
0001386858
HYPERION THERAPEUTICS INC
HPTX
0001293630
Santel Donald J
C/O HYPERION THERAPEUTICS, INC.
2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE
CA
94005
1
1
0
0
CEO & President
Common Stock
2015-05-07
4
U
0
2306
46.00
D
0
D
Common Stock
2015-05-07
4
U
0
10164
46.00
D
0
I
By Donald J. Santel and Kelly L. McGinnis, Trust UA. dated 12/18/08 FBO Margaret Cate Santel
Common Stock
2015-05-07
4
D
0
53875
46.00
D
0
D
Common Stock
2015-05-07
4
D
0
292057
46.00
D
0
D
Stock Option (Right to Buy)
1.28
2015-05-07
4
D
0
303133
46.00
D
2019-11-02
Common Stock
303133
0
D
Stock Option (Right to Buy)
4.08
2015-05-07
4
D
0
6648
46.00
D
2021-04-14
Common Stock
6648
0
D
Stock Option (Right to Buy)
7.31
2015-05-07
4
D
0
88547
46.00
D
2022-04-15
Common Stock
88547
0
D
Stock Option (Right to Buy)
24.46
2015-05-07
4
D
0
143000
46.00
D
2023-04-14
Common Stock
143000
0
D
Stock Option (Right to Buy)
26.74
2015-05-07
4
D
0
111000
46.00
D
2024-03-10
Common Stock
111000
0
D
Stock Option (Right to Buy)
25.97
2015-05-07
4
D
0
70000
46.00
D
2025-02-08
Common Stock
70000
0
D
Stock Option (Right to Buy)
327.95
2015-05-07
4
D
0
169
0.00
D
2017-09-03
Common Stock
169
0
D
Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the issuer.
Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon (the "Merger").
Shares that are being acquired by Horizon in the Merger.
Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger.
Options to acquire shares of issuer common stock that will be cancelled for no consideration in connection with the Merger.
/s/ Sally Brammell, Attorney-in-Fact
2015-05-08